Colorectal Cancer Therapeutics Market - Top Companies and Manufacturers

Companies Dominating the Colorectal Cancer Therapeutics Landscape

Novartis AG
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Pfizer Inc.
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
Bristol-Myers Squibb Company
Bayer AG
Amgen Inc.
Genentech, Inc.
Teva Pharmaceuticals Industries Ltd.
Ipsen Biopharmaceuticals, Inc.

Browse Key Market Insights with Data Illustration:

Colorectal Cancer Therapeutics Market Size & Share, Forecast Report 2037

In the News

Ipsen Biopharmaceuticals, Inc. completed the acquisition of Epizyme Inc. and expanded its oncology portfolio.
Novartis AG announced the promising clinical data for its investigational KRASG12C inhibitor JDQ443, an investigational selective, covalent, and orally bioavailable inhibitor at the annual meeting of the American Association for Cancer Research (AACR)

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of colorectal cancer therapeutics is evaluated at USD 24.11 billion.

The colorectal cancer therapeutics market size was over USD 22.36 billion in 2024 and is projected to reach USD 75.39 billion by 2037, witnessing around 9.8% CAGR during the forecast period i.e., between 2025-2037. Worldwide increasing prevalence of cancer, emerging novel therapies for cancer treatment, significant research on novel drugs, and global surge in geriatric population will boost the market growth.

North America industry is predicted to dominate majority revenue share of 31% by 2037, driven by escalating incidences of colorectal cancer coupled with supportive government initiatives along with rising healthcare expenditure, rising number of colon cancer, and increasing awareness among people regarding the screening of colorectal cancer in the region.

The major players in the market include Novartis AG, Pfizer Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, Bayer AG, Amgen Inc., Genentech, Inc., Teva Pharmaceuticals Industries Ltd., Ipsen Biopharmaceuticals, Inc.

Colorectal Cancer Therapeutics Market - Top Companies and Manufacturers

Companies Dominating the Colorectal Cancer Therapeutics Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How much is the colorectal cancer therapeutics market worth?

Why is the demand for colorectal cancer therapeutics growing?

Which region dominated the majority of colorectal cancer therapeutics industry share?

Who are the top colorectal cancer therapeutics companies?